COP
42
-5
PNW
66
6
INTU
56
-9
PYPL
52
-2
FLS
55
2
TGNA
56
-2
LYB
20
-3
SE
40
-3
EBAY
52
-2
APA
53
-3
EXC
54
4
ICE
64
-3
BAX
53
3
MAR
69
4
CSX
50
-4
ZTS
17
5
AME
69
4
AEE
58
8
NEE
54
2
NI
67
4
COP
42
-5
PNW
66
6
INTU
56
-9
PYPL
52
-2
FLS
55
2
TGNA
56
-2
LYB
20
-3
SE
40
-3
EBAY
52
-2
APA
53
-3
EXC
54
4
ICE
64
-3
BAX
53
3
MAR
69
4
CSX
50
-4
ZTS
17
5
AME
69
4
AEE
58
8
NEE
54
2
NI
67
4
Financhill
Back

Guggenheim Strategic Opportunities Fund Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Sell
49

GOF
Guggenheim Strategic Opportunities Fund

Last Price:
$12.07
Seasonality Move:
0.63%
Sell
33

ZBIO
Zenas BioPharma, Inc.

Last Price:
$36.94
Seasonality Move:
-8.13%
Sell
49
Guggenheim Strategic Opportunities Fund (GOF) is a Sell

Is Guggenheim Strategic Opportunities Fund a Buy, Sell or Hold?

  • The current Guggenheim Strategic Opportunities Fund [GOF] share price is $12.09. The Score for GOF is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • GOF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Zenas BioPharma, Inc. (ZBIO) is a Sell

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $32.59. The Score for ZBIO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • ZBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GOF Stock Price Chart

What is Guggenheim Strategic Opportunities Fund's stock price today?

  • The Guggenheim Strategic Opportunities Fund share price today is $12.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $32.59
    The current trend is moderately bullish and ZBIO is experiencing selling pressure, which indicates risk of future bearish movement.

GOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 35.38 Sell
Chaikin Money Flow: 1214955 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.94 - 12.78) Sell
Bollinger Bands (100): (12.88 - 15.2) Sell

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.39 Buy
Relative Strength Index (14 RSI): 42.51 Sell
Chaikin Money Flow: -433025 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.8 - 39.38) Sell
Bollinger Bands (100): (16.79 - 33.43) Buy

GOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.12 Sell
20-day SMA: 12.17 Sell
50-day SMA: 13.12 Sell
200-day SMA: 14.46 Sell
8-day EMA: 12.15 Sell
20-day EMA: 12.33 Sell
50-day EMA: 12.98 Sell
200-day EMA: 14.21 Sell

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.44 Sell
20-day SMA: 37.66 Sell
50-day SMA: 32.27 Buy
200-day SMA: 17.45 Buy
8-day EMA: 37.61 Sell
20-day EMA: 34.32 Sell
50-day EMA: 23.15 Buy
200-day EMA: 7.97 Buy

Guggenheim Strategic Opportunities Fund Earnings Growth & GOF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.

Guggenheim Strategic Opportunities Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):